South African Medical News

Back to Home Page

Print using browser
Boehringer Ingelheim discontinue Inflammide 200 & 400 Novolizer Powder for inhalation (budesonide)

boehringeringelheimlogo






Dear Healthcare Provider

Boehringer Ingelheim regrets to inform you that INFLAMMIDE 200 & 400 Novolizer Powder for inhalation has been discontinued and will no longer be manufactured.

* This is a drug - read the leaflet carefully before use. 


* Ask your doctor or pharmacist for further information. 


Boehringer Ingelheim apologise in advance for any inconvenience caused by this discontinuation.

For full prescribing information please refer to package insert approved by the Medical Regulatory Authority.
 
Boehringer Ingelheim (Pty) Ltd, 407 Pine Ave, Randburg

You need to be logged in to see more details. Register Now!


Click here to visit the Boehringer Ingelheim website....
Contact: Francesco Martiradonna, National Key Accounts Manager
Telephone: +27 (0) 11 348 2400
E-mail: francesco.martiradonna@boehringer-ingelheim.com
Date: Wednesday, August 16, 2017